Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reviews in Endocrine and Metabolic Disorders
Published in: Reviews in Endocrine and Metabolic Disorders 4/2015

01-12-2015

Introduction to Endocrine Disrupting Chemicals – is it time to act?

Authors: Christian A. Koch, Evanthia Diamanti-Kandarakis

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 4/2015

Login to get access

Excerpt

Endocrine Disrupting Chemicals (EDCs) are considered as an emerging public health issue due to their potency to interfere and deregulate several aspects of the endocrine system physiology in laboratory animals, wildlife, and humans. Human exposure is thought to be constant and universal and has been related with diverse perturbations including reproductive disorders, thyroid and metabolic dysfunction, hormone-dependent cancers and neurodevelopmental diseases. …
Metadata
Title
Introduction to Endocrine Disrupting Chemicals – is it time to act?
Authors
Christian A. Koch
Evanthia Diamanti-Kandarakis
Publication date
01-12-2015
Publisher
Springer US
Published in
Reviews in Endocrine and Metabolic Disorders / Issue 4/2015
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-016-9338-3

Other articles of this Issue 4/2015

Reviews in Endocrine and Metabolic Disorders 4/2015 Go to the issue

EditorialNotes

Preface

ReviewPaper

Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)

ReviewPaper

Toxic chemicals and thyroid function: hard facts and lateral thinking

ReviewPaper

Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients

ReviewPaper

Using systematic reviews for hazard and risk assessment of endocrine disrupting chemicals

ReviewPaper

Methodological issues in human studies of endocrine disrupting chemicals
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits